Cytotoxic T-Lymphocyte-, and Helper T-Lymphocyte-Oriented DNA Vaccination

DNA and Cell Biology

Volumn 23, Issue 2, 2004, Pages 93-106

  Nagata, Toshi ^a   Aoshi, Taiki ^a   Uchijima, Masato ^a   Suzuki, Mina ^a   Koide, Yukio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL ANTIGEN; BETA 2 MICROGLOBULIN; CD40 LIGAND; CYTOKINE; DNA VACCINE; EPITOPE; GAG PROTEIN; GAMMA TUBULIN; GAMMA TUBULIN PROTEIN E7; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERCELLULAR ADHESION MOLECULE 1; LISTERIOLYSIN; LISTERIOLYSIN O [91-99]; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MALARIA VACCINE; METALLOPROTEINASE; METALLOPROTEINASE[84-92]; PROTEIN; PROTEIN B7.1; PROTEIN E7; PROTEIN P60; PROTEIN P60 [217-225]; PROTEIN P60 [301-312]; PROTEIN P60 [449-457]; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS NUCLEOPROTEIN; VIRUS NUCLEOPROTEIN[366-374] BETA 2 MICROGLOBULIN; VIRUS NUCLEOPROTEIN[366-374] GREEN FLUORESCENT PROTEIN;

ADOPTIVE TRANSFER; ANIMAL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BINDING AFFINITY; CELLULAR IMMUNITY; CODON; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; ENHANCER REGION; GENE CONSTRUCT; GENE FUSION; GENE GUN; GENE SEQUENCE; GENE TARGETING; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; GENETICS; HELPER CELL; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGY; INFECTION; INFLUENZA VIRUS; LISTERIA MONOCYTOGENES; LISTERIOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA; METHODOLOGY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; RECOMBINANT DNA TECHNOLOGY; REVIEW; RNA TRANSLATION; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS; UBIQUITINATION; VACCINATION; VACCINE PRODUCTION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS; GENETIC ENGINEERING; IMMUNITY, CELLULAR; LISTERIA INFECTIONS; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA;

ANIMALIA; BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; LISTERIA; LISTERIA MONOCYTOGENES; POSIBACTERIA; VACCINIA VIRUS;

EID: 1242337299     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454904322759902     Document Type: Review

References (118)

1. AKBARI, O., PANJWANI, N., GARCIA, S., TASCON, R., LOWRIE, D., and STOCKINGER, B. (1999). DNA vaccination: Transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189, 169-177.
2. ALARCON, J.B., WAINE, G.W., and MCMANUS, D.P. (1999). DNA vaccines: Technology and application as anti-parasite and anti-microbial agents. Adv. Parasitol. 42, 343-410.
3. ALEXANDER, J., SIDNEY, J., SOUTHWOOD, S., RUPPERT, J., OSEROFF, C., MAEWAL, A., SNOKE, K., SERRA, H.M., KUBO, R.T., SETTE, A., et al. (1994). Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1, 751-761.
4. ALLEN, T.M., VOGEL, T.U., FULLER, D.H., MOTHÉ, B.R., STEFFEN, S., BOYSON, J.E., SHIPLEY, T., FULLER, J., HANKE, T., SETTE, A., et al. (2000). Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from Rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J. Immunol. 164, 4968-4978.
5. AN, L.-L., RODRIGUEZ, F., HARKINS, S., ZHANG, J., and WHITTON, J.L. (2000). Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine. Vaccine 18, 2132-2141.
6. ANDRÉ, S., SEED, B., EBERLE, J., SCHRAUT, W., BÜLTMANN, A., and HAAS, J. (1998). Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72, 1497-1503.
7. ANTÓN, L.C., SCUBERT, U., BACÍK, I., PRINCIOTTA, M.F., WEARSCH, P.A., GIBBS, J., FAY, P.M., REALINI, C., RECHSTEINER, M.C., BENNINK, J.R., et al. (1999). Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146, 113-124.
8. BACHMAIR, A., FINLEY, D., and VARCHAVSKY, A. (1986). In vivo half-life of a protein is a function of its amino-terminal residue. Science 234, 179-186.
9. BERZOFSKY, J.A. (1993). Epitope selection and design of synthetic vaccines: Molecular approaches to enhancing immunogenicity and crossreactivity of engineered vaccines. Ann. NY Acad. Sci. 690, 256-264.
10. BERZOFSKY, J.A., AHLERS, J.D., and BELYAKOV, I.M. (2001). Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 1, 209-219.
11. BOYLE, J.S., BRADY, J.L., and LEW, A.M. (1998). Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392, 408-411.
12. BRYANT, P.W., LENNON-DUMENIL, A.M., FIEBIGER, E., LAGAUDRIERE-GESBERT, C., and PLOEGH, H.L. (2002). Proteolysis and antigen presentation by MHC class II molecules. Adv. Immunol. 80, 71-114.
13. BUSCH, D.H., KERKSIEK, K., and PAMER, E.G. (1999). Processing of Listeria monocytogenes antigens and the in vivo T-cell response to bacterial infection. Immunol. Rev. 172, 163-169.
14. CASARES, S., BRUMEANU, T.-D., BOT, A., and BONA, C.A. (1997a). Protective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus. Viral Immunol. 10, 129-136.
15. CASARES, S., INABA, K., BRUMEANU, T.-D., STEINMAN, R.M., and BONA, C.A. (1997b). Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186, 1481-1486.
16. CHATTERGOON, M., BOYER, J., and WEINER, D.B. (1997). Genetic immunization: A new era in vaccines and immune therapeutics. FASEB J. 11, 753-763.
17. CHENG, L., ZIEGELHOFFER, P.R., and YANG, N.-S. (1993). In vitro promoter activity and transgene exression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455-4459.
18. + T cell responses in gene gun DNA immunization. J. Immunol. 167, 5549-5557.
19. CIERNIK, I.F., BERZOFSKY, J.A., and CARBONE, D.P. (1996). Induction of cytotoxic T lymphoytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156, 2369-2375.
20. CORR, M., LEE, D.J., CARSON, D.A., and TIGHE, H. (1996). Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555-1560.
21. CORR, M., VON DAMM, A., LEE, D.J., and TIGHE, H. (1999). In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol. 163, 4721-4727.
22. COSSART, P., and MENGAUD, J. (1989). Listeria monocytogenes, a model system for the molecular study of intracellular parasitism. Mol. Biol. Med. 6, 463-474.
23. + cells in resistance to primary and secondary infection, delayed-type hypersensitivity and adoptive transfer of resistance. Immunology 71, 107-112.
24. DEL VAL, M., SCHLICHT, H.-J., RUPPERT, T., REDDEHASE, M.J., and KOSZINOWSKI, U.H. (1991). Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66, 1145-1153.
25. DELIYANNIS, G., BOYLE, J.S., BRADY, J.L., BROWN, L.E., and LEW, A.M. (2000). A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc. Natl. Acad. Sci. USA 97, 6676-6680.
26. DEML, L., BOJAK, A., STECK, S., GRAF, M., WILD, J., SCHIRMBECK, R., WOLF, H., and WAGNER, R. (2001). Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 gag protein. J. Virol. 75, 10991-11001.
27. DONNELLY, J.J., ULMER, J.B., SHIVER, J.W., and LIU, M.A. (1997). DNA vaccines. Annu. Rev. Immunol. 15, 617-648.
28. ELIOTT, G., and O'HARE, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
29. EO, S.K., GIERYNSKA, M., KAMAR, A.A., and ROUSE, B.-T. (2001). Prime-boost immunization with DNA vaccine: Mucosal route of administration changes the rules. J. Immunol. 166, 5473-5479.
30. FAN, H., LIN, Q., MORRISSEY, G.R., and KHAVARI, P.A. (1999). Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. 17, 870-872.
31. FELTQUATE, D.M., HEANEY, S., WEBSTER, R.G., and ROBINSON, H.L. (1997). Different T helper cells types and antibody isotypes generated by saline and gene gun DNA immunzation. J. Immunol. 158, 2278-2284.
32. FU, T.M., GUAN, L., FRIEDMAN, A., ULMER, J.B., LIU, M.A., and DONNELLY, J.J. (1998). Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens. Vaccine 16, 1711-1717.
33. FUJII, S., SENJU, S., CHEN, Y.-Z., ANDO, M., MATSUSHITA, S., and NISHIMURA, Y. (1998). The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells. Hum. Immunol. 59, 607-614.
34. GEGINAT, G., LALIC, M., KRETSCHMAR, M., GOEBEL, W., HOF, H., PALM, D., and BUBERT, A. (1998). Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J. Immunol. 160, 6046-6055.
35. GEGINAT, G., SCHENK, S., SKOBERNE, M., GOEBEL, W., and HOF, H. (2001). A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J. Immunol. 166, 1877-1884.
36. GERMAIN, R.N. (1999). Antigen processing and presentation. In Fundamental Immunology, 4th ed., W.E. Paul, ed. (Lippincott-Raven Publishers, Philadelphia) pp. 287-340.
37. GURUNATHAN, S., IRVINE, K.R., WU, C.-Y., COHEN, J.I., THOMAS, E., PRUSSIN, C., RESTIFO, N.P., and SEDER, R.A. (1998). CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol. 161, 4563-4571.
38. GURUNATHAN, S., KLINMAN, D.M., and SEDER, R.A. (2000). DNA vaccines: Immunology, application, and optimization. Annu. Rev. Immunol. 18, 927-974.
39. HANKE, T., NEUMANN, V.C., BLANCHARD, T.J., SWEENEY, P., HILL, A.V.S., SMITH, G.L., and MCMICHAEL, A. (1999). Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccinatin regime. Vaccine 17, 589-596.
40. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175, 1531-1538.
41. HESS, J., SCHAIBLE, U., RAUPACH, B., and KAUFMANN, S.H.E. (2000). Exploiting the immune system: Toward new vaccines against intracellular bacteria. Adv. Immunol. 75, 1-88.
42. HUNG, C.-F., CHENG, W.-F., CHAI, C.-Y., HSU, K.-F., HE, L., LING, M., and WU, T.-C. (2001). Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J. Immunol. 166, 5733-5740.
43. HUNG, C.-F., CHENG, W.-F., HE, L., LING, M., JUANG, J., LIN, C.-T., and WU, T.-C. (2003). Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Cancer Res. 63, 2393-2398.
44. ISHIOKA, G.Y., FIKES, J., HERMANSON, G., LIVINGSTON, B., CRIMI, C., QIN, M., DEL GUERCIO, M.-F., OSEROFF, C., DAHLBERG, C., ALEXANDER, J., et al. (1999). Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162, 3915-3925.
45. IWASAKI, A., DELA CRUZ, C.S., YOUNG, A.R., and BARBER, B.H. (1999). Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization. Vaccine 17, 2081-2088.
46. IWASAKI, A., TORRES, C.A.T., OHASHI, P.S., ROBINSON, H.L., and BARBER, B.H. (1997). The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159, 11-14.
47. JARIEL-ENCONTRE, I., PARIAT, M., MARTIN, F., CARILLO, S., SALVAT, C., and PIECHACZYK, M. (1995). Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26S proteasome. J. Biol. Chem. 270, 11623-11627.
48. JI, H., WANG, T.-L., CHEN, C.-H., PAI, S.I., HUNG, C.-F., LIN, K.-Y., KURMAN, R.J., PARDOLL, D.M., and WU, T.-C. (1999). Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human palillomavirus type 16 E7-expressing tumors. Hum. Gene Ther. 10, 2727-2740.
49. KAUFMANN, S.H.E. (1993). Immunity to intracellular bacteria. Annu. Rev. Immunol. 11, 129-163.
50. 2+ T cells. Infect. Immun. 48, 263-266.
51. KENT, S.J., ZHAO, A., BEST, S.J., CHANDLER, J.D., BOYLE, D.B., and RAMSHOW, I.A. (1998). Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72, 10180-10188.
52. KLINMAN, D.M., YI, A.-K., BEAUCAGE, S.L., CONOVER, J., and KRIEG, A.M. (1996). CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA 93, 2879-2883.
53. KOZAK, M. (1987). An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148.
54. KRIEG, A.M., YI, A.-K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
55. KWISSA, M., VON KAMPEN, J., ZURBRIGGEN, R., GLÜCK, R., REIMANN, J., and SCHIRMBECK, R. (2000). Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control. Vaccine 18, 2337-2344.
56. LADEL, C.H., FLESCH, I.E.A., ARNOLDI, J., and KAUFUMANN, S.H.E. (1994). Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J. Immunol. 153, 3116-3122.
57. LATOUCHE, J.-B., and SADELAIN, M. (2000). Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nat. Biotechnol. 18, 405-409.
58. + T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA, 90, 5214-5218.
59. LIU, M.A., and ULMER, J.B. (2000). Gene-based vaccines. Mol. Ther. 1, 497-500.
60. MAECKER, H.T., UMETSU, D.T., DEKRUYFF, R.H., and LEVY, S. (1998). Cytotoxic T cell responses to DNA vaccination: Dependence on antigen presentation via class II MHC. J. Immunol. 161, 6532-6536.
61. MALCHEREK, G., WIRBLICH, C., WILLCOX, N., RAMMENSEE, H.-G., TROWSDALE, J., and MELMS, A. (1998). MHC class II-associated invariant chain peptide replacement by T cell epitopes: Engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation. Eur. J. Immunol. 28, 1524-1533.
62. MCSHANE, H. (2002). Prime-boost immunization strategies for infectious diseases. Cur. Opin. Mol. Ther. 4, 23-27.
63. + T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination for murine tuberculosis. Infect. Immun. 69, 681-686.
64. MURAKAMI, Y., MATSUFUJI, S., KAMEJI, T., HAYASHI, S., IGARASHI, K., TAMURA, T., TANAKA, K., and ICHIHARA, A. (1992). Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360, 597-599.
65. NAGATA, T., AOSHI, T., SUZUKI, M., UCHIJIMA, M., KIM, Y.-H., YANG, Z., and KOIDE, Y. (2002). Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain. Infect. Immun. 70, 2676-2680.
66. NAGATA, T., HIGASHI, T., AOSHI, T., SUZUKI, M., UCHIJIMA, M., and KOIDE, Y. (2001). Immunization with plasmid DNA encoding MHC class 11 binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization. Vaccine 20, 105-114.
67. NAGATA, T., UCHIJIMA, M., YOSHIDA, A., KAWASHIMA, M., and KOIDE, Y. (1999). Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem. Biophys. Res. Commun. 261, 445-451.
68. NAKAMURA, T., GOJOBORI, T., and IKEMURA, T. (2000). Codon usage tabulated from international DNA sequence databases: Status for the year 2000. Nucleic Acids Res. 28, 292 (http://www.kazusa.or.jp/codon/).
69. NARUM, D.L., KUMAR, S., ROGERS, W.O., FUHRMANN, S.R., LIANG, H., OAKLEY, M., TAYE, A., SIM, B.K.L., and HOFFMAN, S.L. (2001). Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect. Immun. 69, 7250-7253.
70. PAMER, E.G. (1997). Immune response to Listeria monocytogenes. In Host Response to Intracellular Pathogens. S.H.E. Kaufmann, ed. (Spring-Verlag, Heidelberg) pp 131-142.
71. PAMER, E.G., and CRESSWELL, P. (1998). Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16, 323-358.
72. PERTMER, T.M., EISENBRAUN, M.D., MCCABE, D., PRAYAGA, S.K., FULLER, D.H., and HAYNES, J.R. (1995). Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427-1430.
73. PERTMER, T.M., ROBERTS, T.R., and HAYNES, J.R. (1996). Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70, 6119-6125.
74. RAMSHAW, I.A., and RAMSAY, A.J. (2000). The prime-boost strategy: Exciting prospects for improved vaccination. Immunol. Today 21, 163-165.
75. RAZ, E., CARSON, D.A., PARKER, S.E., PARR, T.B., ABAI, A.M., AICHINGER, G., GROMKOWSKI, S.H., SINGH, M., LEW, D., YANKAUCKAS, M.A., et al. (1994). Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519-9523.
76. ROBERTS, A.D., ORDWAY, D.J., and ORME, I.M. (1993). Listeria monocytogenes infection in β2 microglobulin-deficient mice. Infect. Immun. 61, 1113-1116.
77. ROCK, K.L., and GOLDBERG, A.L. (1999). Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17, 739-779.
78. RODRIGUEZ, F., AN, L.L., HARKINS, S., ZHANG, J., YOKOYAMA, M., WIDERA, G., FULLER, J.T., KINCAID, C., CAMPBELL, I.L., and WHITTON, J.L. (1998). DNA immunization with minigenes: Low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72, 5174-5181.
79. + T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting. J. Virol. 75, 10421-10430.
80. RODRIGUEZ, F., ZHANG, J., and WHITTON, J.L. (1997). DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71, 8497-8503.
81. ROMAN, M., MARTIN-OROZCO, E., GOODMAN, J.S., NGUYEN, M.-D., SATO, Y., RONAGHY, A., KORNBLUTH, R.S., RICHMAN, D.D., CARSON, D.A., and RAZ, E. (1997). Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3, 849-854.
82. SAFLEY, S.A., JENSEN, P.E., REAY, P.A., and ZIEGLER, H.K. (1995). Mechanisms of T cell epitope immunodominance analyzed in murine listeriosis. J. Immunol. 155, 4355-4366.
83. + cells, and the effect of administration of recombinant murine interferon γ in listerial infection. J. Exp. Med. 171, 1141-1154.
84. SATO, Y., ROMAN, M., TIGHE, H., LEE, D., CORR, M., NGUYEN, M.-D., SILVERMAN, G.J., LOTZ, M., CARSON, D.A., and RAZ, E. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
85. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4, 397-402.
86. SEDEGAH, M., JONES, T.R., KAUR, M., HEDSTROM, R., HOBART, P., TINE, J.A., and HOFFMAN, S.L. (1998). Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 95, 7648-7653.
87. SHARP, P.M., and LI, W.H. (1987). The codon adaptation index - A measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res. 15, 1281-1295.
88. SHEDLOCK, D.J., and WEINER, D.B. (2000). DNA vaccination: Antigen presentation and the induction of immunity. J. Leukoc. Biol. 68, 793-806.
89. STRUGNELL, R.A., DREW, D., MERCIECA, J., DINATALE, S., FIREZ, N., DUNSTAN, S.J., SIMMONS, C.P., and VADOLAS, J. (1997). DNA vaccines for bacterial infections. Immunol. Cell Biol. 75, 364-369.
90. SULLIVAN, N.J., SANCHEZ, A., ROLLIN, P.E., YANG, Z.-Y., and NABEL, G.J. (2000). Development of a preventive vaccine for Ebora virus infection in primates. Nature 408, 605-609.
91. TAKASHIMA, A., and MORITA, A. (1999). Dendritic cells in genetic immunization. J. Leukoc. Biol. 66, 350-356.
92. TANG, D., DEVIT, M., and JOHNSTON, S.A. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.
93. + cytotoxic T lymphocytes: A novel approach to vaccine design. J. Virol. 72, 2246-2252.
94. THOMSON, S.A., SHERRITT, M.A., MEDVECZKY, J., ELLIOTT, S.L., MOSS, D.J., FERNANDO, G.J.P., BROWN, L.E., and SUHRBIER, A. (1998b). Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J. Immunol. 160, 1717-1723.
95. + T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response. Eur. J. Immunol. 32, 1631-1639.
96. UCHIJIMA, M., YOSHIDA, A., NAGATA, T., and KOIDE, Y. (1998). Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J. Immunol. 161, 5594-5599.
97. UCHIYAMA, H., NAGATA, T., YAMADA, T., UCHIJIMA, M., AOSHI, T., SUDA, T., CHIDA, K., NAKAMURA, H., and KOIDE, Y. (2002). Endosomal/lysosomal targeting of a single helper T-cell epitope of an intracellular bacterium by DNA immunization induces a specific T-cell subset and partial protective immunity in vivo. FEMS Microbiol. Lett. 216, 91-97.
98. 2-microglobulin constructs. J. Immunol. 160, 1598-1605.
99. VAN BERGEN, J., OSSENDORP, F., JORDENS, R., MOMMAAS, A.M., DRIJFHOUT, J.-W., and KONING, F. (1999). Get into the groove! Targeting antigens to MHC class II. Immuno. Rev. 172, 87-96.
100. VAN BERGEN, J., SCHOENBERGER, S.P., VERRECK, F., AMONS, R., OFFRINGA, R., and KONING, F. (1997). Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP. Proc. Natl. Acad. Sci. USA 94, 7499-7502.
101. + T cell responses by invariant chain based DNA vaccines. Vaccine 19, 1515-1519.
102. VAN UDEN, J., and RAZ, E. (2000). Introduction to immunotimulatory DNA sequences. Springer Semin. Immunopathol. 22, 1-9.
103. VARSHAVSKY, A. (1992). The N-end rule. Cell 69, 725-735.
104. VELDERS, M.P., WEIJZEN, S., EIBEN, G.L., ELMISHAD, A.G., KLOETZEL, P.-M., HIGGINS, T., CICCARELLI, R.B., EVANS, M., MAN, S., SMITH, L., et al. (2001). Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine. J. Immunol. 166, 5366-5373.
105. VIDALIN, O., TANAKA, E., SPENGLER, U., TRÉPO, C., and INCHAUSPÉ, G. (1999). Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination. DNA Cell. Biol. 18, 611-621.
106. VINNER, L., NIELSEN, H.V., BRYDER, K., CORBET, S., NIELSEN, C., and FOMSGAARD, A. (1999). Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons. Vaccine 17, 2166-2175.
107. WHITTON, J.L., RODRIGUEZ, F., ZHANG, J., and HASSETT, D.E. (1999). DNA immunization: mechanistic studies. Vaccine 17, 1612-1619.
108. WHITTON, J.L., SHENG, N., OLDSTONE, M.B.A., and MCKEE, T.A. (1993). A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose Virus Challenge. J. Virol. 67, 348-352.
109. WOLKERS, M.C., TOEBES, M., OKABE, M., HAANEN, J.B.A.G., and SCHUMACHER, T.N.M. (2002). Optimizing the efficacy of epitope-directed DNA vaccination. J. Immunol. 168, 4998-5004.
110. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
111. WU, T.-C., GUARNIERI, F.G., STAVELEY-O'CARROLL, K.F., VISCIDI, R.P., LEVITSKY, H.I., HEDRICK, L., CHO, K.R., AUGUST, J.T., and PARDOLL, D.M. (1995). Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc. Nat. Acad. Sci. USA 92, 11671-11675.
112. WU, Y., and KIPPS, T.J. (1997). Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes, J. Immunol. 159, 6037-6043.
113. YAMADA, T., UCHIYAMA, H., NAGATA, T., UCHIJIMA, M., SUDA, T., CHIDA, K., NAKAMURA, H., and KOIDE, Y. (2001). Protective cytotoxic T lymphocyte responses induced by DNA immunization against immunodominant and subdominant epitopes of Listeria monocytogenes are noncompetitive. Infect. Immun. 69, 3427-3430.
114. YOSHIDA, A., NAGATA, T., UCHIJIMA, M., HIGASHI, T., and KOIDE, Y. (2000). Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine 18, 1725-1729.
115. + T cells and IFN-γ by gene gun DNA vaccination with a minigene encoding a CTL epitope of Listeria monocytogenes. Vaccine 19, 4297-4306.
116. YOU, Z., HUANG, X., HESTER, J., TOH, H.C., and CHEN, S.-Y. (2001). Targeting dendritic cells to enhance DNA vaccine potency. Cancer Res. 61, 3704-3711.
117. ZHI, Q.X., ZHENNING, H., YIJIE, W., and ERTL, H.C.J. (1997). The effect of interferon-γ on genetic immunization. Vaccine 15, 896-898.
118. ZIEGLER, H.K., SAFLEY, S.A., and HILTBOLD, E. (1994). Definition of T cell epitopes of Listeria monocytogenes and regulation of antigen processing by the bacterial exotoxin listeriolysin-O (LLO). In Antigen Processing and Presentation. R.E. Humphreys, S.K. Pierce, eds. (Academic Press, San Diego, CA) pp 295-307.